 Ocugen Inc. NASDAQ:OCGN shares were trading higher Tuesday after the Indian government approved Bharat Biotechs COVID-19 vaccine Covaxin, for children between the ages of 2 and 18. Ocugen is partnered with Bharat Biotech. 